financetom
Business
financetom
/
Business
/
Update: Amazon Ends Development of Fertility Tracking Product
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Amazon Ends Development of Fertility Tracking Product
Nov 13, 2024 1:42 PM

04:23 PM EST, 11/13/2024 (MT Newswires) -- (Updates with Amazon ( AMZN ) comment starting in the first paragraph.)

Amazon.com ( AMZN ) discontinued plans to develop an at-home fertility tracker, Margaret Callahan, a company spokesperson, said Wednesday in an email to MT Newswires.

The secretive project, codenamed Encore, had been underway for four years and involved the development of a fertility monitoring device and companion smartphone application, CNBC reported earlier Wednesday, citing internal documents and people familiar with the matter.

The Encore team was part of Amazon's ( AMZN ) Grand Challenge, also known as its Special Projects division, CNBC said. About 100 employees will be affected, Amazon ( AMZN ) said.

"Following a recent review, we've decided to discontinue this project within Grand Challenge, and we're working directly with employees whose roles are impacted to support them through the transition and help them find other opportunities within Amazon ( AMZN )," Callahan said in the email.

The product faced technical and cost issues, CNBC said.

Amazon ( AMZN ) shares rose 0.1% in after-hours trading.

Price: 214.32, Change: +0.22, Percent Change: +0.11

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
European earnings outlook brightens despite US-China tariff escalation
European earnings outlook brightens despite US-China tariff escalation
Oct 14, 2025
(Reuters) -Analysts are a little more upbeat about European companies' third-quarter results than a week ago, according to the latest estimates compiled by LSEG I/B/E/S, despite the latest flare-up in trade tensions between the U.S. and China. European companies are on average expected to report a 0.5% year-on-year increase in third-quarter earnings, the data showed. That is better than the...
Form 8.3 - NCC group plc
Form 8.3 - NCC group plc
Oct 14, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee...
Toyo Begins Commercial Operations at Solar Module Facility in Houston; Shares Rise
Toyo Begins Commercial Operations at Solar Module Facility in Houston; Shares Rise
Oct 14, 2025
09:36 AM EDT, 10/14/2025 (MT Newswires) -- Toyo (TOYO) said Tuesday that its solar module manufacturing facility in the Houston, Texas area received a certificate of occupancy issued by the city. The company said the certificate allows it to begin full commercial operations at the facility, which it said is designed to produce up to 1 gigawatts of high-efficiency solar...
Trinity Capital to Provide $130 Million in Capital to Candel Therapeutics
Trinity Capital to Provide $130 Million in Capital to Candel Therapeutics
Oct 14, 2025
09:39 AM EDT, 10/14/2025 (MT Newswires) -- Trinity Capital ( TRIN ) said Tuesday it will provide $130 million in growth capital to Candel Therapeutics ( CADL ) . Trinity Capital's ( TRIN ) investment will be used to support Candel's clinical development of CAN-2409, along with pre-commercial and launch activities for CAN-2409 in prostate cancer, pending regulatory approval, Trinity...
Copyright 2023-2026 - www.financetom.com All Rights Reserved